Elucidating the 'Jekyll and Hyde' nature of PXR: The case for discovering antagonists or allosteric antagonists

Arunima Biswas, Sridhar Mani, Matthew R. Redinbo, Matthew D. Krasowski, Hao Li, Sean Ekins

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The pregnane X receptor belongs to the nuclear hormone receptor superfamily and is involved in the transcriptional control of numerous genes. It was originally thought that it was a xenobiotic sensor controlling detoxification pathways. Recent studies have shown an increasingly important role in inflammation and cancer, supporting its function in abrogating tissue damage. PXR orthologs and PXR-like pathways have been identified in several non-mammalian species which corroborate a conserved role for PXR in cellular detoxification. In summary, PXR has a multiplicity of roles in vivo and is being revealed as behaving like a "Jekyll and Hyde" nuclear hormone receptor. The importance of this review is to elucidate the need for discovery of antagonists of PXR to further probe its biology and therapeutic applications. Although several PXR agonists are already reported, virtually nothing is known about PXR antagonists. Here, we propose the development of PXR antagonists through chemical, genetic and molecular modeling approaches. Based on this review it will be clear that antagonists of PXR and PXR-like pathways will have widespread utility in PXR biology and therapeutics.

Original languageEnglish (US)
Pages (from-to)1807-1815
Number of pages9
JournalPharmaceutical Research
Volume26
Issue number8
DOIs
StatePublished - Aug 2009

Fingerprint

Detoxification
Cytoplasmic and Nuclear Receptors
Molecular modeling
Xenobiotics
Molecular Biology
Genes
Tissue
Inflammation
Sensors
Therapeutics
Neoplasms
pregnane X receptor

Keywords

  • Agonists
  • Antagonists
  • Machine learning
  • Pharmacophore
  • Pregnane X receptor

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Organic Chemistry
  • Molecular Medicine
  • Pharmacology (medical)
  • Biotechnology
  • Pharmacology

Cite this

Elucidating the 'Jekyll and Hyde' nature of PXR : The case for discovering antagonists or allosteric antagonists. / Biswas, Arunima; Mani, Sridhar; Redinbo, Matthew R.; Krasowski, Matthew D.; Li, Hao; Ekins, Sean.

In: Pharmaceutical Research, Vol. 26, No. 8, 08.2009, p. 1807-1815.

Research output: Contribution to journalArticle

Biswas, Arunima ; Mani, Sridhar ; Redinbo, Matthew R. ; Krasowski, Matthew D. ; Li, Hao ; Ekins, Sean. / Elucidating the 'Jekyll and Hyde' nature of PXR : The case for discovering antagonists or allosteric antagonists. In: Pharmaceutical Research. 2009 ; Vol. 26, No. 8. pp. 1807-1815.
@article{e6ca410f8c224c9297c5bdd9fe945726,
title = "Elucidating the 'Jekyll and Hyde' nature of PXR: The case for discovering antagonists or allosteric antagonists",
abstract = "The pregnane X receptor belongs to the nuclear hormone receptor superfamily and is involved in the transcriptional control of numerous genes. It was originally thought that it was a xenobiotic sensor controlling detoxification pathways. Recent studies have shown an increasingly important role in inflammation and cancer, supporting its function in abrogating tissue damage. PXR orthologs and PXR-like pathways have been identified in several non-mammalian species which corroborate a conserved role for PXR in cellular detoxification. In summary, PXR has a multiplicity of roles in vivo and is being revealed as behaving like a {"}Jekyll and Hyde{"} nuclear hormone receptor. The importance of this review is to elucidate the need for discovery of antagonists of PXR to further probe its biology and therapeutic applications. Although several PXR agonists are already reported, virtually nothing is known about PXR antagonists. Here, we propose the development of PXR antagonists through chemical, genetic and molecular modeling approaches. Based on this review it will be clear that antagonists of PXR and PXR-like pathways will have widespread utility in PXR biology and therapeutics.",
keywords = "Agonists, Antagonists, Machine learning, Pharmacophore, Pregnane X receptor",
author = "Arunima Biswas and Sridhar Mani and Redinbo, {Matthew R.} and Krasowski, {Matthew D.} and Hao Li and Sean Ekins",
year = "2009",
month = "8",
doi = "10.1007/s11095-009-9901-7",
language = "English (US)",
volume = "26",
pages = "1807--1815",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Elucidating the 'Jekyll and Hyde' nature of PXR

T2 - The case for discovering antagonists or allosteric antagonists

AU - Biswas, Arunima

AU - Mani, Sridhar

AU - Redinbo, Matthew R.

AU - Krasowski, Matthew D.

AU - Li, Hao

AU - Ekins, Sean

PY - 2009/8

Y1 - 2009/8

N2 - The pregnane X receptor belongs to the nuclear hormone receptor superfamily and is involved in the transcriptional control of numerous genes. It was originally thought that it was a xenobiotic sensor controlling detoxification pathways. Recent studies have shown an increasingly important role in inflammation and cancer, supporting its function in abrogating tissue damage. PXR orthologs and PXR-like pathways have been identified in several non-mammalian species which corroborate a conserved role for PXR in cellular detoxification. In summary, PXR has a multiplicity of roles in vivo and is being revealed as behaving like a "Jekyll and Hyde" nuclear hormone receptor. The importance of this review is to elucidate the need for discovery of antagonists of PXR to further probe its biology and therapeutic applications. Although several PXR agonists are already reported, virtually nothing is known about PXR antagonists. Here, we propose the development of PXR antagonists through chemical, genetic and molecular modeling approaches. Based on this review it will be clear that antagonists of PXR and PXR-like pathways will have widespread utility in PXR biology and therapeutics.

AB - The pregnane X receptor belongs to the nuclear hormone receptor superfamily and is involved in the transcriptional control of numerous genes. It was originally thought that it was a xenobiotic sensor controlling detoxification pathways. Recent studies have shown an increasingly important role in inflammation and cancer, supporting its function in abrogating tissue damage. PXR orthologs and PXR-like pathways have been identified in several non-mammalian species which corroborate a conserved role for PXR in cellular detoxification. In summary, PXR has a multiplicity of roles in vivo and is being revealed as behaving like a "Jekyll and Hyde" nuclear hormone receptor. The importance of this review is to elucidate the need for discovery of antagonists of PXR to further probe its biology and therapeutic applications. Although several PXR agonists are already reported, virtually nothing is known about PXR antagonists. Here, we propose the development of PXR antagonists through chemical, genetic and molecular modeling approaches. Based on this review it will be clear that antagonists of PXR and PXR-like pathways will have widespread utility in PXR biology and therapeutics.

KW - Agonists

KW - Antagonists

KW - Machine learning

KW - Pharmacophore

KW - Pregnane X receptor

UR - http://www.scopus.com/inward/record.url?scp=67650082856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650082856&partnerID=8YFLogxK

U2 - 10.1007/s11095-009-9901-7

DO - 10.1007/s11095-009-9901-7

M3 - Article

C2 - 19415465

AN - SCOPUS:67650082856

VL - 26

SP - 1807

EP - 1815

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 8

ER -